EDGAR Filing Documents for 0001140361-21-014778

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001140361-21-014778

Filing Date

2021-04-28

Accepted

2021-04-28 16:36:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	nc10021152x2_defa14a.htm	DEFA14A	20582
2		nc10021152x2_nc01.jpg	GRAPHIC	696058
3		nc10021152x2_nc02.jpg	GRAPHIC	485551
	Complete submission text file	0001140361-21-014778.txt		1649314

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37587 | Film No.: 21864810
SIC: 2834 Pharmaceutical Preparations